Breaking Boundaries in Pharmaceutical 

Innovation

Biotrajectory search

Simulation

online

Dynamics-based Drug Discovery 

Flexible, demand-driven resources to optimize the value of your research investment

Proposing a molecular design paradigm and overcoming the challenges of new drug design for undruggable targets

Drug Discovery Solution Provider based on Molecular Dynamics Simulation

Applying our comprehensive  understanding of protein structure and flexibility to drug discovery in a dynamic environment

Full process

DIVAMICS provides full process services in multiple areas

DIVAMICS is an interdisciplinary biopharmaceutical company driven by cutting-edge technologies such as artificial intelligence, quantum mechanics, and molecular simulation algorithms .

Wide range

Concentrate, focus, professional

DIVAMICS's value and

professional scientific team


  • Dr. Kenneth. M. Merz Jr.

    Dr. Kenneth. M. Merz Jr.

    Sr. Scientist

    0.00

    0.00

  • Dr. Hao Liu, CSO

    Dr. Hao Liu, CSO

    CSO

    0.00

    0.00

  • Jinbo Yang, M.A.

    Jinbo Yang, M.A.

    CFO

    0.00

    0.00

  • Xinyi Shen, M.S.

    Xinyi Shen, M.S.

    Director of Strategy and Business Development

    0.00

    0.00

  • Jiang Chang

    Jiang Chang

    Medicinal Chemistry

    0.00

    0.00

DICAMICS's value


CEO

Dr. John Zheng

DIVAMICS was awarded Suzhou Industrial Park Science and Technology Leadership Project at the beginning of its establishment, and was approved for the Suzhou Gusu Leadership Talent Project in 2022. One of the company’s core algorithms, the MovableType  free energy algorithm, has been acknowledged and recommended by Roald Hoffman, the 1981 Nobel Prize winner in Chemistry. 

DIVAMICS have a wide range of cooperation  include ...


News

Academic achievements

DIVAMICS Latest 

news and academic achievements

View ranking